Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer

Chisei Tei, Toyohiko Miyazaki, Naoaki Kuji, Mamoru Tanaka, Kou Sueoka, Yasunori Yoshimura

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: To determine the effect of danazol on in vitro fertilization- embryo transfer (IVF-ET) patients who failed to conceive in previous attempts despite having embryos with optimal morphology, whether endometriosis is present or not. STUDY DESIGN: In this prospective, randomized, controlled study, of 81 patients who experienced unexplained failures of IVF-ET despite having goodmorphology embryos, 40 received danazol (400 mg/d orally for 12 weeks) following the unsuccessful IVF-ET cycle. The next IVF-ET was performed within three months of the first spontaneous ovulation after danazol administration. The remaining 41 patients constituted the control group, and in them the next IVF-ET was performed within six months after the previous failed cycle. RESULTS: Conception occurred in 16 of 40 (40%) danazol-treated patients at the subsequent cycle and showed a significant increase when compared with 8 of 41 (19.5%) control subjects (P < .05), though the number of embryos with optimal morphology decreased after danazol treatment. CONCLUSION: Danazol may be used for patients who have had repeated failures of IVF-ET despite having morphologically optimal embryos and may be useful for increasing receptivity of the endometrium in these patients.

Original languageEnglish
Pages (from-to)541-546
Number of pages6
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume43
Issue number6
Publication statusPublished - 1998 Jun

Fingerprint

Danazol
Embryo Transfer
Pregnancy Rate
Fertilization in Vitro
Embryonic Structures
Endometriosis
Endometrium
Ovulation
Control Groups

Keywords

  • Danazol
  • Embryo transfer
  • Fertilization in vitro
  • Infertility, female
  • Pregnancy outcome

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer. / Tei, Chisei; Miyazaki, Toyohiko; Kuji, Naoaki; Tanaka, Mamoru; Sueoka, Kou; Yoshimura, Yasunori.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 43, No. 6, 06.1998, p. 541-546.

Research output: Contribution to journalArticle

@article{82c092cbe9cd4d3caf404a180841166a,
title = "Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer",
abstract = "OBJECTIVE: To determine the effect of danazol on in vitro fertilization- embryo transfer (IVF-ET) patients who failed to conceive in previous attempts despite having embryos with optimal morphology, whether endometriosis is present or not. STUDY DESIGN: In this prospective, randomized, controlled study, of 81 patients who experienced unexplained failures of IVF-ET despite having goodmorphology embryos, 40 received danazol (400 mg/d orally for 12 weeks) following the unsuccessful IVF-ET cycle. The next IVF-ET was performed within three months of the first spontaneous ovulation after danazol administration. The remaining 41 patients constituted the control group, and in them the next IVF-ET was performed within six months after the previous failed cycle. RESULTS: Conception occurred in 16 of 40 (40{\%}) danazol-treated patients at the subsequent cycle and showed a significant increase when compared with 8 of 41 (19.5{\%}) control subjects (P < .05), though the number of embryos with optimal morphology decreased after danazol treatment. CONCLUSION: Danazol may be used for patients who have had repeated failures of IVF-ET despite having morphologically optimal embryos and may be useful for increasing receptivity of the endometrium in these patients.",
keywords = "Danazol, Embryo transfer, Fertilization in vitro, Infertility, female, Pregnancy outcome",
author = "Chisei Tei and Toyohiko Miyazaki and Naoaki Kuji and Mamoru Tanaka and Kou Sueoka and Yasunori Yoshimura",
year = "1998",
month = "6",
language = "English",
volume = "43",
pages = "541--546",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "6",

}

TY - JOUR

T1 - Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer

AU - Tei, Chisei

AU - Miyazaki, Toyohiko

AU - Kuji, Naoaki

AU - Tanaka, Mamoru

AU - Sueoka, Kou

AU - Yoshimura, Yasunori

PY - 1998/6

Y1 - 1998/6

N2 - OBJECTIVE: To determine the effect of danazol on in vitro fertilization- embryo transfer (IVF-ET) patients who failed to conceive in previous attempts despite having embryos with optimal morphology, whether endometriosis is present or not. STUDY DESIGN: In this prospective, randomized, controlled study, of 81 patients who experienced unexplained failures of IVF-ET despite having goodmorphology embryos, 40 received danazol (400 mg/d orally for 12 weeks) following the unsuccessful IVF-ET cycle. The next IVF-ET was performed within three months of the first spontaneous ovulation after danazol administration. The remaining 41 patients constituted the control group, and in them the next IVF-ET was performed within six months after the previous failed cycle. RESULTS: Conception occurred in 16 of 40 (40%) danazol-treated patients at the subsequent cycle and showed a significant increase when compared with 8 of 41 (19.5%) control subjects (P < .05), though the number of embryos with optimal morphology decreased after danazol treatment. CONCLUSION: Danazol may be used for patients who have had repeated failures of IVF-ET despite having morphologically optimal embryos and may be useful for increasing receptivity of the endometrium in these patients.

AB - OBJECTIVE: To determine the effect of danazol on in vitro fertilization- embryo transfer (IVF-ET) patients who failed to conceive in previous attempts despite having embryos with optimal morphology, whether endometriosis is present or not. STUDY DESIGN: In this prospective, randomized, controlled study, of 81 patients who experienced unexplained failures of IVF-ET despite having goodmorphology embryos, 40 received danazol (400 mg/d orally for 12 weeks) following the unsuccessful IVF-ET cycle. The next IVF-ET was performed within three months of the first spontaneous ovulation after danazol administration. The remaining 41 patients constituted the control group, and in them the next IVF-ET was performed within six months after the previous failed cycle. RESULTS: Conception occurred in 16 of 40 (40%) danazol-treated patients at the subsequent cycle and showed a significant increase when compared with 8 of 41 (19.5%) control subjects (P < .05), though the number of embryos with optimal morphology decreased after danazol treatment. CONCLUSION: Danazol may be used for patients who have had repeated failures of IVF-ET despite having morphologically optimal embryos and may be useful for increasing receptivity of the endometrium in these patients.

KW - Danazol

KW - Embryo transfer

KW - Fertilization in vitro

KW - Infertility, female

KW - Pregnancy outcome

UR - http://www.scopus.com/inward/record.url?scp=0031869635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031869635&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 541

EP - 546

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 6

ER -